We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.72%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.3B
AUM Growth
+$558M
(+9.7%)
Cap. Flow
+$692M
Cap. Flow
% of AUM
10.99%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
2,519
New
476
Increased
567
Reduced
586
Closed
886
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Brazil ETF
EWZ
|
+$82.7M |
| 2 |
iShares MSCI India ETF
INDA
|
+$63.2M |
| 3 |
GRMN
Garmin
GRMN
|
+$48.5M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$48.5M |
| 5 |
lululemon athletica
LULU
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$213M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$119M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64M |
| 4 |
IBM
IBM
|
+$51.6M |
| 5 |
Lowe's Companies
LOW
|
+$46.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.35% |
| 2 | Financials | 12.85% |
| 3 | Technology | 11.81% |
| 4 | Industrials | 11.41% |
| 5 | Healthcare | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Atkore
ATKR
$2.59B
| $457K | 0.01% |
23,000
+5,343
| +30% | +$115K |
|
1127
Central Garden & Pet Co Class A
CENTA
$2.41B
| $455K | 0.01% |
+14,354
| New | +$431K |
|
1128
Independent Bank Corp
IBCP
$776M
| $453K | 0.01% |
19,800
+2,220
| +13% | +$51.8K |
|
|
BOLD
1129
DELISTED
Audentes Therapeutics, Inc
BOLD
| $448K | 0.01% |
14,900
+5,598
| +60% | +$190K |
|
1130
Halozyme
HALO
$9.72B
| $447K | 0.01% |
22,824
-43,797
| -66% | -$848K |
|
|
ZSAN
1131
DELISTED
Zosano Pharma Corporation
ZSAN
| $445K | 0.01% |
+2,524
| New | +$844K |
|
|
CJ
1132
DELISTED
C&J Energy Services, Inc.
CJ
| $444K | 0.01% |
17,200
-367
| -2% | -$10.5K |
|
1133
Madrigal Pharmaceuticals
MDGL
$12.6B
| $443K | 0.01% |
3,792
-133
| -3% | -$16.4K |
|
|
HOME
1134
DELISTED
At Home Group Inc.
HOME
| $443K | 0.01% |
13,840
+2,218
| +19% | +$68.1K |
|
1135
Alkermes
ALKS
$8.82B
| $442K | 0.01% |
7,625
-1,792
| -19% | -$105K |
|
|
MODN
1136
DELISTED
MODEL N, INC.
MODN
| $442K | 0.01% |
24,500
-21,866
| -47% | -$364K |
|
1137
Viavi Solutions
VIAV
$9.75B
| $439K | 0.01% |
45,158
+23,101
| +105% | +$220K |
|
1138
Atara Biotherapeutics
ATRA
$71.2M
| $437K | 0.01% |
448
-370
| -45% | -$337K |
|
1139
Charles River Laboratories
CRL
$10.9B
| $437K | 0.01% |
4,096
-9,176
| -69% | -$989K |
|
|
BZUN
1140
Baozun
BZUN
$144M
| $436K | 0.01% |
+9,513
| New | +$374K |
|
1141
Liberty Broadband Class A
LBRDA
$4.14B
| $436K | 0.01% |
+5,140
| New | +$460K |
|
|
MRTX
1142
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $436K | 0.01% |
+14,200
| New | +$394K |
|
|
CSII
1143
DELISTED
Cardiovascular Systems, Inc.
CSII
| $436K | 0.01% |
19,900
+8,360
| +72% | +$201K |
|
1144
Materion
MTRN
$5.01B
| $434K | 0.01% |
+8,504
| New | +$434K |
|
|
IMGN
1145
DELISTED
Immunogen Inc
IMGN
| $433K | 0.01% |
+41,200
| New | +$407K |
|
|
GMS
1146
DELISTED
GMS Inc
GMS
| $431K | 0.01% |
14,100
-20,735
| -60% | -$703K |
|
|
LDL
1147
DELISTED
Lydall, Inc.
LDL
| $430K | 0.01% |
8,917
+2,025
| +29% | +$97.2K |
|
1148
Enova International
ENVA
$5.91B
| $429K | 0.01% |
+19,465
| New | +$392K |
|
|
CALA
1149
DELISTED
Calithera Biosciences, Inc
CALA
| $429K | 0.01% |
3,408
-230
| -6% | -$35.9K |
|
1150
Collegium Pharmaceutical
COLL
$1.14B
| $427K | 0.01% |
16,708
-9,387
| -36% | -$224K |
|
Similar funds
Squarepoint's Q1 2018 Portfolio in Review
As of Q1 2018, Squarepoint held 2,519 positions worth $6.3B, up 9.7% from $5.74B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Squarepoint deployed $692M of net new capital in Q1 2018, opening 476 new positions and adding to 567 existing holdings. Its largest new stake was iShares MSCI India ETF: 1,779,444 shares worth $60.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $119M trimmed.
- Squarepoint's largest Q1 2018 buy was iShares MSCI India ETF: 1,779,444 shares worth $60.7M.
- Squarepoint added most to iShares MSCI Brazil ETF in Q1 2018, an estimated $82.7M increase.
- Squarepoint's biggest Q1 2018 reduction was Invesco QQQ Trust, cutting an estimated $119M.
- Squarepoint fully exited iShares Core MSCI Emerging Markets ETF in Q1 2018, selling an estimated $213M.
- Squarepoint's ten largest holdings make up 10% of its $6.3B portfolio in Q1 2018.
- Squarepoint opened 476 new positions and closed 886 in Q1 2018.
- Squarepoint's portfolio value rose 9.7% quarter-over-quarter to $6.3B.
Based on Squarepoint's 13F filing for Q1 2018, filed 15 May 2018.